NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Novo Nordisk A/S (CO: NOVO-B)

 
NOVO-B Technical Analysis
5
As on 30th Mar 2026 NOVO-B STOCK Price closed @ 231.15 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 479.44 & Strong Sell for SHORT-TERM with Stoploss of 652.91 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NOVO-BSTOCK Price

Open 228.00 Change Price %
High 231.15 1 Day 2.65 1.16
Low 227.15 1 Week -6.75 -2.84
Close 231.15 1 Month -76.50 -24.87
Volume 5643821 1 Year -516.45 -69.08
52 Week High 790.30 | 52 Week Low 228.50
 
CO Denmark Most Active Stocks
SAS 0.01 0.00%
DONKEY 7.90 0.00%
NOVO-B 231.15 1.16%
VWS 183.15 4.15%
CONFRZ 0.02 0.00%
VJBA 7.33 0.41%
ORSTED 153.00 7.03%
DANSKE 305.00 1.23%
SHAPE 5.03 30.65%
GREENH 0.41 -6.82%
 
CO Denmark Top Gainers Stocks
HYDRCT 0.60 46.34%
ATLA-DKK 10.50 34.96%
SHAPE 5.03 30.65%
HYPE 3.66 22.00%
DKIEEU 249.00 15.81%
SAME 1.45 10.69%
SAME 1.45 10.69%
ASTRLS 1.15 8.49%
ORSTED 153.00 7.03%
NETC 373.40 6.69%
 
CO Denmark Top Losers Stocks
MONSO 0.10 -28.57%
VALUER 0.25 -21.88%
BLVIS-A 0.40 -18.37%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
 
 
NOVO-B
Daily Charts
NOVO-B
Intraday Charts
Whats New @
Bazaartrend
NOVO-B
Free Analysis
 
NOVO-B Important Levels Intraday
RESISTANCE238.86
RESISTANCE236.39
RESISTANCE234.86
RESISTANCE233.33
SUPPORT228.97
SUPPORT227.44
SUPPORT225.91
SUPPORT223.44
 
NOVO-B Forecast March 2026
4th UP Forecast448.71
3rd UP Forecast378.94
2nd UP Forecast335.81
1st UP Forecast292.68
1st DOWN Forecast169.62
2nd DOWN Forecast126.49
3rd DOWN Forecast83.36
4th DOWN Forecast13.59
 
NOVO-B Weekly Forecast
4th UP Forecast312.28
3rd UP Forecast286.26
2nd UP Forecast270.18
1st UP Forecast254.09
1st DOWN Forecast208.21
2nd DOWN Forecast192.12
3rd DOWN Forecast176.04
4th DOWN Forecast150.02
 
NOVO-B Forecast2026
4th UP Forecast1336.96
3rd UP Forecast982.32
2nd UP Forecast763.11
1st UP Forecast543.9
1st DOWN Forecast-81.6
2nd DOWN Forecast-300.81
3rd DOWN Forecast-520.02
4th DOWN Forecast-874.66
 
 
NOVO-B Other Details
Segment EQ
Market Capital 1565371138048.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
NOVO-B Address
NOVO-B
 
NOVO-B Latest News
 
Your Comments and Response on Novo Nordisk A/S
 
NOVO-B Business Profile
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Lund University to develop treatment for Parkinson's diseases; and bluebird bio, Inc. to develop genome editing treatments for children and adult patients. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark. Address: Novo Allé 1, Bagsvaerd, Denmark, 2880
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service